Healthcare provider profile · identity verified

Murali Ramadurai, M.D.

Internal Medicine · NEWTON, MA · NPI 1922057017

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	919	63
Furosemide	Furosemide	795	62
Trazodone Hcl	Trazodone Hcl	706	92
Atorvastatin Calcium	Atorvastatin Calcium	556	93
Levothyroxine Sodium	Levothyroxine Sodium	487	71
Metoprolol Succinate	Metoprolol Succinate	441	56
Sertraline Hcl	Sertraline Hcl	439	34
Gabapentin	Gabapentin	419	53
Tamsulosin Hcl	Tamsulosin Hcl	351	41
Lisinopril	Lisinopril	339	41
Amlodipine Besylate	Amlodipine Besylate	323	45
Quetiapine Fumarate	Quetiapine Fumarate	288	35
Mirtazapine	Mirtazapine	281	39
Metoprolol Tartrate	Metoprolol Tartrate	271	38
Potassium Chloride	Potassium Chloride	256	34
Escitalopram Oxalate	Escitalopram Oxalate	242	32
Duloxetine Hcl	Duloxetine Hcl	231	27
Donepezil Hcl	Donepezil Hcl	193	26
Omeprazole	Omeprazole	184	30
Citalopram Hbr	Citalopram Hydrobromide	179	20
Memantine Hcl	Memantine Hcl	151	27
Metformin Hcl	Metformin Hcl	146	22
Levetiracetam	Levetiracetam	139	12
Pantoprazole Sodium	Pantoprazole Sodium	123	27
Clopidogrel	Clopidogrel Bisulfate	122	15
Latanoprost	Latanoprost	118	23
Torsemide	Torsemide	117	18
Simvastatin	Simvastatin	116	13
Finasteride	Finasteride	115	19
Xarelto	Rivaroxaban	114	suppressed
Allopurinol	Allopurinol	112	16
Losartan Potassium	Losartan Potassium	109	17
Spironolactone	Spironolactone	109	12
Fluoxetine Hcl	Fluoxetine Hcl	102	14
Jardiance	Empagliflozin	101	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	89	suppressed
Buspirone Hcl	Buspirone Hcl	88	11
Carvedilol	Carvedilol	88	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	86	11
Olanzapine	Olanzapine	83	suppressed
Montelukast Sodium	Montelukast Sodium	76	12
Brimonidine Tartrate	Brimonidine Tartrate	75	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	73	12
Digoxin	Digoxin	72	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	69	43
Rosuvastatin Calcium	Rosuvastatin Calcium	69	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	67	suppressed
Valsartan	Valsartan	65	suppressed
Lorazepam	Lorazepam	59	19
Entresto	Sacubitril/Valsartan	57	suppressed
Atenolol	Atenolol	55	suppressed
Oxycodone Hcl	Oxycodone Hcl	55	16
Aripiprazole	Aripiprazole	54	suppressed
Warfarin Sodium	Warfarin Sodium	54	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	52	suppressed
Divalproex Sodium	Divalproex Sodium	51	13
Myrbetriq	Mirabegron	50	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	46	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	45	20
Lamotrigine	Lamotrigine	44	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	42	40
Amiodarone Hcl	Amiodarone Hcl	39	suppressed
Bumetanide	Bumetanide	38	suppressed
Diltiazem Hcl	Diltiazem Hcl	34	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	34	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	34	suppressed
Bupropion Hcl	Bupropion Hcl	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Famotidine	Famotidine	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	11
Lumigan	Bimatoprost	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	30	12
Doxycycline Hyclate	Doxycycline Hyclate	30	17
Timolol Maleate	Timolol Maleate	30	suppressed
Memantine Hcl Er	Memantine Hcl	29	suppressed
Santyl	Collagenase Clostridium Hist.	29	11
Colchicine	Colchicine	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	suppressed
Trulicity	Dulaglutide	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	suppressed
Zonisamide	Zonisamide	25	suppressed
Azithromycin	Azithromycin	24	21
Dutasteride	Dutasteride	24	suppressed
Estradiol	Estradiol	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	13
Arexvy	Rsvpref3 Antigen/As01e/Pf	23	19
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Carbamazepine	Carbamazepine	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	suppressed
Risperidone	Risperidone	23	suppressed
Rytary	Carbidopa/Levodopa	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Prednisone	Prednisone	22	suppressed
Procrit	Epoetin Alfa	22	suppressed
Xcopri	Cenobamate	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Nystatin	Nystatin	20	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	19	17
Doxepin Hcl	Doxepin Hcl	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Vancomycin Hcl	Vancomycin Hcl	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Humalog	Insulin Lispro	18	suppressed
Levemir	Insulin Detemir	18	suppressed
Trimethoprim	Trimethoprim	18	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Nyamyc	Nystatin	17	11
Tolterodine Tartrate	Tolterodine Tartrate	17	suppressed
Baclofen	Baclofen	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	13
Sucralfate	Sucralfate	16	suppressed
Thyroid	Thyroid,pork	16	suppressed
Calcitriol	Calcitriol	15	suppressed
Erythromycin	Erythromycin Base	15	11
Lactulose	Lactulose	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	15	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	15	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	15	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error